News & Press Releases


PRESS RELEASE

Melior Pharmaceuticals Enrolls Last Subject in Phase 2b Study with Tolimidone for Type 2 Diabetes

October 16, 2018

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Pharmaceuticals Initiates Phase 2B Study with MLR-1023 for Type 2 Diabetes

October 3, 2017

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Pharmaceuticals Announces Positive Phase 2A Results in Type 2 Diabetes Study

June 13, 2016

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Discovery Announces Spinout of Melior Pharmaceuticals II, LLC

May 10, 2016

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Pharmaceuticals Achieves Partnership Milestone with Bukwang Pharmaceutical Co.

March 15, 2016

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Discovery Receives Patent Approval from U.S. Patent and Trademark Office for New Parkinson's Disease Drug Candidate

June 10, 2015

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Pharmaceuticals Initiates Phase 2 Study with MLR-1023 for Type 2 Diabetes

March 3, 2015

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action

December 11, 2014

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Pharmaceuticals Receives First Performance Milestone Payment from Bukwang Pharmaceutical

October 7, 2014

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co.

December 4, 2013

READ MORE DOWNLOAD PDF
PRESS RELEASE

Melior Announces Two Publications Describing New Therapeutic Opportunity in Diabetes

April 17, 2012

READ MORE DOWNLOAD PDF